BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/29/2024 10:56:26 AM | Browse: 16 | Download: 0
Category |
Infectious Diseases |
Manuscript Type |
Case Report |
Article Title |
Septic shock due to cytomegalovirus colitis associated with rituximab use: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Siddharth Patel, Jordan Jay, Prutha Pathak, Mc Anto Antony and Mrudula Thiriveedi |
Funding Agency and Grant Number |
|
Corresponding Author |
Siddharth Patel, MBBS, Attending Doctor, Director, Department of Internal Medicine, Decatur Morgan Hospital, 1201 7th Street SE, Decatur, AL 35601, United States. sidd8801@gmail.com |
Key Words |
Cytomegalovirus colitis; Rituximab use; Immunocompromised status; Septic shock; Pancytopenia; Case report |
Core Tip |
With increasing use of biologics in medicine, there has been emergence of opportunistic infections. Cytomegalovirus (CMV) infections remain asymptomatic or cause only mild symptoms in most immunocompetent adults. However, it can cause infectious complications in immunocompromised individuals-especially those with defective T-lymphocyte function. Rituximab (RTX) use is associated with B-lymphocyte depletion and increased risk of infections. However, CMV infections after long-term RTX are uncommon. Our case describes septic shock due to CMV colitis associated with RTX use which is an extremely rare entity. It highlights the need for consideration of rare opportunistic infections in all patients on biologics. |
Citation |
Patel S, Jay J, Pathak P, Antony MA, Thiriveedi M. Septic shock due to cytomegalovirus colitis associated with rituximab use: A case report. World J Virol 2024; In press |
|
Received |
|
2024-08-03 21:05 |
|
Peer-Review Started |
|
2024-08-03 21:05 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-17 03:50 |
|
Revised |
|
2024-09-27 04:02 |
|
Second Decision |
|
2024-10-29 02:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-29 10:56 |
|
Articles in Press |
|
2024-10-29 10:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345